This document lists links to various ministries of health and medicine regulatory authority websites around the world, organized by region. It includes over 150 links to websites for countries in Africa, the Eastern Mediterranean, Asia, Europe, and the Americas. The websites provided are for organizations that regulate medicines and pharmaceutical products in their respective countries.
Product type- Drug development - Departments of facility- Registration pathwa...Asmaa Khalil
Ā
In this video you will know the detailed information about:
šøDepartments of the manufacturing sites.
šøSteps of drug product development.
šøRegulatory Affairs department.
šøRegistration pathway.
šøProduct Type (Innovator "RLD" / Generic / Hybrid).
šøAll medicines must grant a Marketing Authorization (MA) in order to be placed on the market legally in the country.
šøThe ultimate purpose of marketing authorization is to ensure that safe, effective & high-quality medicines, as to protect public health.
https://youtu.be/edUEFt681iM
#asmaa_khalil_ctd
Different Export Prices of Medicinal Drugs.pdfAsmaa Khalil
Ā
The document discusses different price levels for drugs from factory to public. The EX-Factory price is the cost from the seller's factory. The wholesaler price is between the factory and pharmacies. The public or retail price is what pharmacies charge the public. It also defines CIF, FOB, and CFR pricing terms for exports, with CIF including cost, freight, and insurance, FOB including just cost, and CFR including cost and freight but not insurance. Export prices generally use CIF or FOB, rarely CFR.
Global medicine regulatory authorities websites.pdfAsmaa Khalil
Ā
This document lists regulatory authorities' websites for medicines in various countries and regions. It includes 38 websites for countries in Africa and the Eastern Mediterranean, 21 websites for countries in Europe and European authorities, 19 websites for countries in the Americas, 36 websites for countries in Asia, and 11 websites for countries in Russia and the CIS region. The websites listed are mainly for countries' ministries of health and medicines regulatory authorities.
This document provides an overview of Gulf and European registration pathways for pharmaceutical products. It compares the registration processes and requirements between the Gulf Cooperation Council (GCC) countries and the European Union (EU). Specifically, it outlines the national and centralized registration options in GCC countries and EU, compares Module 1 requirements and chemistry, manufacturing and controls (CMC) data requirements between GCC and EU dossiers. It also provides timelines and performance targets for the different registration procedures in Saudi Food and Drug Authority (SFDA) and the EU.
The document provides tips for improving CVs and developing careers in the pharmaceutical field. It recommends including personal details, education, computer skills, training courses, and checking for spelling errors on CVs. It also lists various career opportunities for pharmacists and free online trainings from global organizations covering medicine, pharmaceutical industry topics, and good manufacturing practices. Contact details are provided for networking and sharing beneficial resources.
The document lists 17 new molecular entities approved by the FDA in 2022, including drugs to treat insomnia, eczema, hemolytic anemia, myelofibrosis, seizures, prostate cancer, vulvovaginal candidiasis, hypertrophic cardiomyopathy, Helicobacter pylori infection, type 2 diabetes mellitus, plaque psoriasis, polyneuropathy of hereditary transthyretin-mediated amyloidosis, hepatorenal syndrome, elevated intraocular pressure, amyotrophic lateral sclerosis, bile duct cancer, acute myeloid leukemia, non-small cell lung cancer, HIV-1 infection, and as a hyperpolarized contrast agent. Each drug is listed with its active ingredient
To formally attest to a signature on a document, a notary public will sign and stamp the document with their seal after verifying the identity of the signer. For countries that have signed the Hague Convention, only an apostille is needed, which is a certificate attached to the document by the Ministry of Foreign Affairs to authenticate the notary's seal. If the country is not part of the Hague Convention, the document must go through a process of legalization where each country's authorities further authenticate the document so it will be recognized as valid.
The document discusses various aspects of process validation including:
- The three stages of process validation: process design, process qualification, and continued process verification.
- Key definitions related to process validation including qualification, validation, and continued process verification.
- The importance of process validation in ensuring consistent quality and reducing risk.
- Key documents required for stage 1 process design including development reports and control strategy documents.
Product type- Drug development - Departments of facility- Registration pathwa...Asmaa Khalil
Ā
In this video you will know the detailed information about:
šøDepartments of the manufacturing sites.
šøSteps of drug product development.
šøRegulatory Affairs department.
šøRegistration pathway.
šøProduct Type (Innovator "RLD" / Generic / Hybrid).
šøAll medicines must grant a Marketing Authorization (MA) in order to be placed on the market legally in the country.
šøThe ultimate purpose of marketing authorization is to ensure that safe, effective & high-quality medicines, as to protect public health.
https://youtu.be/edUEFt681iM
#asmaa_khalil_ctd
Different Export Prices of Medicinal Drugs.pdfAsmaa Khalil
Ā
The document discusses different price levels for drugs from factory to public. The EX-Factory price is the cost from the seller's factory. The wholesaler price is between the factory and pharmacies. The public or retail price is what pharmacies charge the public. It also defines CIF, FOB, and CFR pricing terms for exports, with CIF including cost, freight, and insurance, FOB including just cost, and CFR including cost and freight but not insurance. Export prices generally use CIF or FOB, rarely CFR.
Global medicine regulatory authorities websites.pdfAsmaa Khalil
Ā
This document lists regulatory authorities' websites for medicines in various countries and regions. It includes 38 websites for countries in Africa and the Eastern Mediterranean, 21 websites for countries in Europe and European authorities, 19 websites for countries in the Americas, 36 websites for countries in Asia, and 11 websites for countries in Russia and the CIS region. The websites listed are mainly for countries' ministries of health and medicines regulatory authorities.
This document provides an overview of Gulf and European registration pathways for pharmaceutical products. It compares the registration processes and requirements between the Gulf Cooperation Council (GCC) countries and the European Union (EU). Specifically, it outlines the national and centralized registration options in GCC countries and EU, compares Module 1 requirements and chemistry, manufacturing and controls (CMC) data requirements between GCC and EU dossiers. It also provides timelines and performance targets for the different registration procedures in Saudi Food and Drug Authority (SFDA) and the EU.
The document provides tips for improving CVs and developing careers in the pharmaceutical field. It recommends including personal details, education, computer skills, training courses, and checking for spelling errors on CVs. It also lists various career opportunities for pharmacists and free online trainings from global organizations covering medicine, pharmaceutical industry topics, and good manufacturing practices. Contact details are provided for networking and sharing beneficial resources.
The document lists 17 new molecular entities approved by the FDA in 2022, including drugs to treat insomnia, eczema, hemolytic anemia, myelofibrosis, seizures, prostate cancer, vulvovaginal candidiasis, hypertrophic cardiomyopathy, Helicobacter pylori infection, type 2 diabetes mellitus, plaque psoriasis, polyneuropathy of hereditary transthyretin-mediated amyloidosis, hepatorenal syndrome, elevated intraocular pressure, amyotrophic lateral sclerosis, bile duct cancer, acute myeloid leukemia, non-small cell lung cancer, HIV-1 infection, and as a hyperpolarized contrast agent. Each drug is listed with its active ingredient
To formally attest to a signature on a document, a notary public will sign and stamp the document with their seal after verifying the identity of the signer. For countries that have signed the Hague Convention, only an apostille is needed, which is a certificate attached to the document by the Ministry of Foreign Affairs to authenticate the notary's seal. If the country is not part of the Hague Convention, the document must go through a process of legalization where each country's authorities further authenticate the document so it will be recognized as valid.
The document discusses various aspects of process validation including:
- The three stages of process validation: process design, process qualification, and continued process verification.
- Key definitions related to process validation including qualification, validation, and continued process verification.
- The importance of process validation in ensuring consistent quality and reducing risk.
- Key documents required for stage 1 process design including development reports and control strategy documents.
How to implement a successful regulatory due diligence.pdfAsmaa Khalil
Ā
How to implement a successful regulatory due diligence, in order to grant the DP MA license on a short time frame?, and What are the Formatting requirements for eCTD Publishing?
Introduction about CTD, NeeS & eCTD.pdfAsmaa Khalil
Ā
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive function. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms for those who already suffer from conditions like depression and anxiety.
The document discusses common conflicts and pains that can lead to delays in the drug registration process from a commercial point of view. It identifies several key challenges, including lacking a project plan, regulatory intelligence, and issues with CMC data for both drug substances and drug products. Specific problems are outlined, such as invalid certificates, missing documentation, and inconsistencies between dossier sections. Recommendations are provided on how to address these challenges to minimize timelines and cut costs in the registration process.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive function. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
This document summarizes the different types of marketing authorizations (MAs) in the European Union. There are national MAs granted by individual countries, as well as mutual recognition procedures (MRP), decentralized procedures (DCP), and centralized procedures (CP) which allow approval in multiple EU states. The MRP and DCP rely on one state conducting an initial assessment, while the CP provides a single approval valid across all EU states. Applications must demonstrate a positive benefit-risk assessment based on quality, safety, and efficacy considerations.
This document provides information about career opportunities for pharmacists and how to build a career. It discusses roles in various practice settings like community pharmacies, hospitals, and the pharmaceutical industry. It also mentions roles in government agencies, academia, and research. The document then provides tips for career development like obtaining additional education and skills through online courses from organizations like USP, WHO, and Uppsala Monitoring Centre. It emphasizes the importance of ongoing learning and lists social media and networking platforms like LinkedIn for connecting with others in the field.
This document provides information about career opportunities for pharmacists and how to build a career. It discusses roles in various practice settings like community pharmacy, hospitals, and industry. Industry roles include departments like quality assurance, production, and regulatory affairs. Other career paths include government agencies and academic/research. The document then provides suggestions for education and skills development like online courses from USP, WHO, and Uppsala Monitoring Centre on topics like GMP, pharmacovigilance, and COVID-19. It also recommends connecting on LinkedIn and Facebook for virtual meetings on career planning, entrepreneurship, and digital skills.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
Ā
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
Ā
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Integrating Ayurveda into Parkinsonās Management: A Holistic ApproachAyurveda ForAll
Ā
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinsonās care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
Ā
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Ā
Overall life span (LS) was 1671.7Ā±1721.6 days and cumulative 5YS reached 62.4%, 10 years ā 50.4%, 20 years ā 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6Ā±1723.6 days), 22 ā more than 10 years (LS=5571Ā±1841.8 days). 67 LCP died because of LC (LS=471.9Ā±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
How to implement a successful regulatory due diligence.pdfAsmaa Khalil
Ā
How to implement a successful regulatory due diligence, in order to grant the DP MA license on a short time frame?, and What are the Formatting requirements for eCTD Publishing?
Introduction about CTD, NeeS & eCTD.pdfAsmaa Khalil
Ā
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive function. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms for those who already suffer from conditions like depression and anxiety.
The document discusses common conflicts and pains that can lead to delays in the drug registration process from a commercial point of view. It identifies several key challenges, including lacking a project plan, regulatory intelligence, and issues with CMC data for both drug substances and drug products. Specific problems are outlined, such as invalid certificates, missing documentation, and inconsistencies between dossier sections. Recommendations are provided on how to address these challenges to minimize timelines and cut costs in the registration process.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive function. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
This document summarizes the different types of marketing authorizations (MAs) in the European Union. There are national MAs granted by individual countries, as well as mutual recognition procedures (MRP), decentralized procedures (DCP), and centralized procedures (CP) which allow approval in multiple EU states. The MRP and DCP rely on one state conducting an initial assessment, while the CP provides a single approval valid across all EU states. Applications must demonstrate a positive benefit-risk assessment based on quality, safety, and efficacy considerations.
This document provides information about career opportunities for pharmacists and how to build a career. It discusses roles in various practice settings like community pharmacies, hospitals, and the pharmaceutical industry. It also mentions roles in government agencies, academia, and research. The document then provides tips for career development like obtaining additional education and skills through online courses from organizations like USP, WHO, and Uppsala Monitoring Centre. It emphasizes the importance of ongoing learning and lists social media and networking platforms like LinkedIn for connecting with others in the field.
This document provides information about career opportunities for pharmacists and how to build a career. It discusses roles in various practice settings like community pharmacy, hospitals, and industry. Industry roles include departments like quality assurance, production, and regulatory affairs. Other career paths include government agencies and academic/research. The document then provides suggestions for education and skills development like online courses from USP, WHO, and Uppsala Monitoring Centre on topics like GMP, pharmacovigilance, and COVID-19. It also recommends connecting on LinkedIn and Facebook for virtual meetings on career planning, entrepreneurship, and digital skills.
The document discusses the benefits of exercise for mental health. Regular physical activity can help reduce anxiety and depression and improve mood and cognitive functioning. Exercise causes chemical changes in the brain that may help protect against mental illness and improve symptoms.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
Ā
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
Ā
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Integrating Ayurveda into Parkinsonās Management: A Holistic ApproachAyurveda ForAll
Ā
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinsonās care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
Ā
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Ā
Overall life span (LS) was 1671.7Ā±1721.6 days and cumulative 5YS reached 62.4%, 10 years ā 50.4%, 20 years ā 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6Ā±1723.6 days), 22 ā more than 10 years (LS=5571Ā±1841.8 days). 67 LCP died because of LC (LS=471.9Ā±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
Ā
Weāre talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganongās Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
3. Ministries of health websites in Africa & Eastern Mediterranean
24.Qatar: https://www.moph.gov.qa/pages/default.aspx
25.Saudi Arabia: www.sfda.gov.sa
https://www.moh.gov.sa/Pages/Default.aspx
26.Senegal: www.sante.gouv.sn
27.South Africa: www.mccza.com
28.Sudan: www.nmpb.gov.sd
29.Syria: http://www.moh.gov.sy/Default.aspx?tabid=257&language=en-US
30.Swaziland:
http://www.gov.sz/index.php?option=com_content&view=article&id=267&I
temid=403
31.Tunisia: http://www.dpm.tn/index.php/medicament/humain/guide-de-l-
enregistrement
4. Ministries of health websites in Africa & Eastern Mediterranean
32. Turkey: https://www.titck.gov.tr/ https://www.saglik.gov.tr/
33.United Republic of Tanzania: www.tfda.or.tz
34.United Arab Emirates: https://www.mohap.gov.ae/ar/Pages/default.aspx
35.Yemen: http://www.sbd-ye.org/ http://www.mophp-
ye.org/arabic/index.html
36.Uganda: www.nda.or.ug
37.Zambia: http://www.zamra.co.zm/guidelines/
38.Zimbabwe: http://www.mcaz.co.zw/index.php/circulars-download
5. Ministries of health websites in Asia
1. Australia: https://www.tga.gov.au/ https://www.health.gov.au/
2. Afghanistan: http://gdpa.gov.af/fa https://moph.gov.af/
3. Bangladesh: www.dgda.gov.bd http://www.mohfw.gov.bd/
4. Bhutan: www.health.gov.bt http://dra.gov.bt/
5. Brunei Darussalam: http://www.moh.gov.bn/Pages/Home.aspx
6. Cambodia: https://www.ddfcambodia.com/ http://moh.gov.kh/
7. China: http://eng.sfda.gov.cn/WS03/CL0755/
http://english.nmpa.gov.cn/ http://en.nhc.gov.cn/
8. East Timor: http://www.moh.gov.tl/
9. Fiji: http://www.health.gov.fj/
10.Hong Kong: http://www.drugoffice.gov.hk/eps/do/en/level.html
https://www.drugoffice.gov.hk/eps/do/index.html
https://www.mdd.gov.hk/english/news/news.html
https://www.dh.gov.hk/ www.psdh.gov.hk
6. Ministries of health websites in Asia
11. India: www.cdsco.nic.in
12. Indonesia: www.binfar.depkes.go.id
http://www.depkes.go.id/index.php https://www.pom.go.id/new/
https://www.kemkes.go.id/
13. Japan: www.pmda.go.jp https://www.mhlw.go.jp/index.html
14. Korea: http://www.mfds.go.kr/eng/index.do
15. Kyrgyzstan: http://www.pharm.kg/
16. Laos: http://www.fdd.gov.la/index.php
https://www.moh.gov.la/index.php/lo-la/
17. Malaysia: https://npra.gov.my/index.php/my/
https://portal.mda.gov.my/ http://www.moh.gov.my/
7. Ministries of health websites in Asia
18.Maldives: www.mfda.gov.mv http://www.health.gov.mv/
19.Mongolia: www.moh.mn
20.Myanmar: http://www.fda.gov.mm/ http://mohs.gov.mm/
21.Nepal: www.dda.gov.np http://www.mohp.gov.np/en/
22.New Zealand: https://www.medsafe.govt.nz/
https://www.health.govt.nz/
23.Pakistan: http://www.dra.gov.pk/ http://www.nhsrc.gov.pk/
24.Papua New Guinea: https://www.health.gov.pg/subindex.php?pharm=1
http://www.health.gov.pg/
25.Philippine: https://www.fda.gov.ph/ https://www.doh.gov.ph/
8. Ministries of health websites in Asia
26. Singapore: https://www.hsa.gov.sg/ https://www.moh.gov.sg/
27.Sri Lanka: http://203.94.76.60/DRA/home.htm
http://www.health.gov.lk/moh_final/english/
http://nmra.gov.lk/index.php?lang=en http://www.health.gov.lk/
28.Taiwan: https://www.fda.gov.tw/EN/index.aspx
https://www.mohw.gov.tw/mp-1.html
29.Thailand: http://www.fda.moph.go.th/Pages/HomeP_D2.aspx
https://www.moph.go.th/
30.Vietnam: www.dav.gov.vn https://www.moh.gov.vn/
9. Ministries of health websites in America
1. Argentina: www.anmat.gov.ar
2. Bahamas: www.phabahamas.org
3. Brazil: www.anvisa.gov.br
4. Canada: www.hc-sc.gc.ca
5. Chile: www.ispch.cl
6. Colombia: www.invima.gov.co
7. Costa Rica: www.ministeriodesalud.go.cr
8. Cuba: www.cecmed.sld.cu
9. Dominican Republic: www.drogasyfarmacias.gov.do
10.Honduras: www.dgrs.gob.hn
11.Mexico: www.cofepris.gob.mx
10. Ministries of health websites in America
12. Panama: www.minsa.gob.pa
13.Paraguay: www.mspbs.gov.py
14.Peru: www.digemid.minsa.gob.pe
15.Trinidad and Tobago: www.health.gov.tt
16.United States of America: www.fda.gov
17.Uruguay: www.msp.gub.uy
11. Ministries of European health authorities
Austria (AT)
https://aspregister.basg.gv.at/aspregister/faces/aspregister.jspx?_afrLoop=777
14876005150091&_afrWindowMode=0&_adf.ctrl-state=ucwvsudqc_14
https://www.ages.at/startseite/
Belgium (BE)
https://www.famhp.be/en https://www.health.belgium.be/en
Bulgaria (BG)
https://www.bda.bg/en/ http://www.mh.government.bg/en/
12. Ministries of European health authorities
Croatia (HR)
http://www.almp.hr/en/ https://zdravstvo.gov.hr/
Cyprus (CY)
https://www.moh.gov.cy/moh/phs/phs.nsf/dmlindex_gr/dmlindex_gr?OpenDocum
ent
https://www.moh.gov.cy/moh/moh.nsf/index_en/index_en?OpenDocument
Czech Republic (CZ)
http://www.sukl.eu/
https://www.mzcr.cz/en/Info.aspx?aspxerrorpath=/en/default.aspx
Denmark (DK)
https://laegemiddelstyrelsen.dk/en/
https://www.sum.dk/English.aspx
13. Ministries of European health authorities
Estonia (EE)
https://www.ravimiamet.ee/en
https://www.sm.ee/en
https://www.terviseamet.ee/en/medical-devices
Finland (FI)
http://www.fimea.fi/
https://stm.fi/en/frontpage
France (FR)
http://www.ansm.sante.fr/
https://solidarites-sante.gouv.fr/
Germany (DE)
https://www.bfarm.de/DE/Home/home_node.html
https://www.bundesgesundheitsministerium.de/en/en.html
14. Ministries of European health authorities
Greece (EL)
http://www.eof.gr/web/guest;jsessionid=aa3757a8cc0e508ac70993240a6f
https://www.moh.gov.gr/
Hungary (HU)
https://www.ogyei.gov.hu/
https://www.kormany.hu/en/ministry-of-human-resources
Ireland (IE)
https://www.hpra.ie/
https://www.gov.ie/en/organisation/department-of-health/
Italy (IT)
https://www.aifa.gov.it/
http://www.salute.gov.it/portale/p5_11.jsp
15. Ministries of European health authorities
Latvia (LV)
https://www.zva.gov.lv/
http://www.vm.gov.lv/en/
Lithuania (LT)
https://www.vvkt.lt/
http://sam.lrv.lt/en/
Luxembourg (LU)
http://sante.public.lu/fr/politique-sante/ministere-sante/index.html
Malta (MT)
http://www.medicinesauthority.gov.mt/home?l=1
https://www.mccaa.org.mt/
https://deputyprimeminister.gov.mt/en/Pages/health.aspx
16. Ministries of European health authorities
Netherlands (NL)
https://english.cbg-meb.nl/
https://english.farmatec.nl/
https://www.government.nl/ministries/ministry-of-health-welfare-and-sport
https://www.igj.nl/
Poland (PL)
http://www.urpl.gov.pl/en/office
https://www.gov.pl/web/zdrowie
http://www.gif.gov.pl/
Portugal (PT)
https://www.infarmed.pt/
https://www.sns.gov.pt/?cpp=1
http://www.infarmed.pt/web/infarmed/redirecionamento
http://app7.infarmed.pt/infomed/inicio.php
17. Ministries of European health authorities
Romania (RO)
https://www.anm.ro/en/
http://www.ms.ro/
Slovakia (SK)
https://www.sukl.sk/
https://www.health.gov.sk/Titulka
Slovenia (SI)
https://www.jazmp.si/
https://www.gov.si/en/state-authorities/ministries/ministry-of-health/
Spain (ES)
https://www.aemps.gob.es/?lang=en
https://www.mscbs.gob.es/en/directoa/home.htm
18. Ministries of European health authorities
Sweden (SE)
https://lakemedelsverket.se/english/
https://www.government.se/government-of-sweden/ministry-of-health-and-social-
affairs/
United Kingdom (UK)
https://www.gov.uk/government/organisations/medicines-and-healthcare-products-
regulatory-agency
https://www.gov.uk/government/organisations/department-of-health-and-social-care
Iceland (IS)
https://www.ima.is/
https://www.government.is/ministries/ministry-of-health/
19. Ministries of European health authorities
Liechtenstein ( )
https://www.llv.li/
https://www.llv.li/inhalt/1908/amtsstellen/amt-fur-gesundheit
Norway ( )
https://legemiddelverket.no/English
https://www.regjeringen.no/en/dep/hod/id421/
Switzerland:
https://www.swissmedic.ch/swissmedic/en/home.html
https://www.bag.admin.ch/bag/en/home.html
Albania:
https://shendetesia.gov.al/
https://www.salut.ad/
20. Ministries of European health authorities
Andorra:
https://www.salut.ad/
Macedonia:
š« Agency for medicines and Medical Device (MALMED) malmed.gov.mk
š« Ministry of health zdravstvo.gov.mk
Moldova:
https://amdm.gov.md/en/about-us
https://msmps.gov.md/en
Montenegro:
https://www.calims.me/Portal/faces/glavna.jspx?_afrLoop=1206032431985518
1&_afrWindowMode=0&_adf.ctrl-state=k0bwvauw4_4
http://www.mzdravlja.gov.me/ministarstvo
21. Ministries of European health authorities
San Marino:
http://www.sanita.sm/on-line/home.html
Serbia:
https://www.alims.gov.rs/eng/
https://www.zdravlje.gov.rs/
Ukraine:
http://dls.gov.ua/en/
https://moz.gov.ua/